We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pan... Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Show more
THE WOODLANDS, TX, April 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies...
Live webcast on Wednesday, May 1st at 3:20 PM ET THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...
Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity Company developing potential breakthrough two-fold technology that can...
Preclinical study demonstrates potential of Autonomix technology to make renal denervation safer and more effective Ongoing advancement of sensing and ablation technologies toward proof-of-concept...
Live webcast with members of the Autonomix management team, on Thursday, April 11th at 12:00 PM ET THE WOODLANDS, TX, April 08, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX...
Live webcast presentation on Thursday, April 4th at 3:55 PM ET THE WOODLANDS, TX, March 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a...
Live webcast presentation on Wednesday, March 20th at 11:50 AM ET THE WOODLANDS, TX, March 20, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a...
Proven executive with 28 years of success building winning B2C & B2B businesses, brands, and teams for premier consumer, healthcare, and medical technology brands THE WOODLANDS, TX, March 19...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.43 | 14.6757679181 | 2.93 | 3.53 | 2.81 | 21761 | 3.08235849 | CS |
4 | 0.3 | 9.80392156863 | 3.06 | 3.53 | 2.5 | 42737 | 2.83911898 | CS |
12 | -2.08 | -38.2352941176 | 5.44 | 6.09 | 2.5 | 57234 | 3.71643215 | CS |
26 | -4.24 | -55.7894736842 | 7.6 | 7.6 | 2.5 | 65968 | 4.01074017 | CS |
52 | -4.24 | -55.7894736842 | 7.6 | 7.6 | 2.5 | 65968 | 4.01074017 | CS |
156 | -4.24 | -55.7894736842 | 7.6 | 7.6 | 2.5 | 65968 | 4.01074017 | CS |
260 | -4.24 | -55.7894736842 | 7.6 | 7.6 | 2.5 | 65968 | 4.01074017 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions